Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML
Stock Information for Vaxil Bio Ltd.
Loading
Please wait while we load your information from QuoteMedia.